Latest Mapatumumab Stories
CALGARY, March 24 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX: ONC, NASDAQ: ONCY) today announced that it has completed patient enrollment in its U.S.
SEATTLE, Feb. 23, 2011 /PRNewswire/ -- Cell Therapeutics, Inc.
CALGARY, Feb. 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
ROCKVILLE, Md., Feb. 4, 2011 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), today announced the publication of key papers on the clinical and preclinical development of ENMD-2076, an Aurora A/angiogenic kinase inhibitor.
CALGARY, Jan. 18 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
WALTHAM, Mass., Jan.
An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial.
A clinical trial of a potential new targeted treatment drug has provided powerful evidence that it can halt or reverse the growth of lung tumors characterized by a specific genetic abnormality.
NEW YORK, Oct. 27 /PRNewswire-FirstCall/ -- Pfizer Inc.
Novocure reported today that patients with advanced non-small cell lung cancer (NSCLC) achieved a significant increase in survival time when tumor treating fields (TTF) therapy was added to chemotherapy, as compared to previously reported outcomes for patients receiving chemotherapy alone.
- One of the side scenes of the stage in a theater, or the space included between the side scenes.
- The outside stock exchange, or “curb market,” of Paris.
- A flute or groove on the blade of a sword.
- A section of stage scenery placed in a wing of a theatre.